Cargando…

microRNA-378a-5p iS a novel positive regulator of melanoma progression

Evaluating the expression levels of miR-378a-5p both in a large melanoma patient cohort from The Cancer Genome Atlas database and in melanoma patients from our Institute, we found that miR-378a-5p is upregulated in metastatic melanoma specimens. miR-378a-5p expression was also increased in melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tupone, Maria Grazia, D’Aguanno, Simona, Di Martile, Marta, Valentini, Elisabetta, Desideri, Marianna, Trisciuoglio, Daniela, Donzelli, Sara, Sacconi, Andrea, Buglioni, Simonetta, Ercolani, Cristiana, Biagioni, Alessio, Fibbi, Gabriella, Fattore, Luigi, Mancini, Rita, Ciliberto, Gennaro, Blandino, Giovanni, Del Bufalo, Donatella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021836/ https://www.ncbi.nlm.nih.gov/pubmed/32060259 http://dx.doi.org/10.1038/s41389-020-0203-6

Ejemplares similares

BCL-X(L) overexpression promotes tumor progression-associated properties
por: Trisciuoglio, Daniela, et al.
Publicado: (2017)

Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
por: Di Martile, Marta, et al.
Publicado: (2020)

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
por: D’Aguanno, Simona, et al.
Publicado: (2018)

Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein
por: Trisciuoglio, D, et al.
Publicado: (2016)

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells
por: Di Martile, Marta, et al.
Publicado: (2020)

SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
por: Valentini, Elisabetta, et al.
Publicado: (2021)

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
por: Di Martile, Marta, et al.
Publicado: (2018)

Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models
por: Di Martile, Marta, et al.
Publicado: (2021)

Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
por: D’Aguanno, Simona, et al.
Publicado: (2020)

Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules
por: Valentini, Elisabetta, et al.
Publicado: (2022)

Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
por: Trisciuoglio, Daniela, et al.
Publicado: (2018)

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target
por: Di Martile, Marta, et al.
Publicado: (2016)

Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
por: Di Martile, Marta, et al.
Publicado: (2016)

Hypoxia-dependent drivers of melanoma progression
por: D’Aguanno, Simona, et al.
Publicado: (2021)

Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study
por: Marchesi, Francesco, et al.
Publicado: (2018)

LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells
por: Maresca, Giovanna, et al.
Publicado: (2012)

Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin
por: Castaldo, Vittorio, et al.
Publicado: (2023)

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer
por: Del Bufalo, Donatella, et al.
Publicado: (2014)

Bcl-2-like protein-10 increases aggressive features of melanoma cells
por: Del Bufalo, Donatella, et al.
Publicado: (2022)

Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma
por: Fattore, Luigi, et al.
Publicado: (2020)

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
por: Lucianò, Anna Maria, et al.
Publicado: (2023)

Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90
por: Trisciuoglio, Daniela, et al.
Publicado: (2010)

Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance
por: Fattore, Luigi, et al.
Publicado: (2022)

A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
por: Terrenato, Irene, et al.
Publicado: (2022)

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available
por: Ercolani, Cristiana, et al.
Publicado: (2022)

Special Issue “Precision Oncology in Melanoma Progression”
por: D’Aguanno, Simona
Publicado: (2021)

Editorial: Methods in cancer genetics
por: D’Aguanno, Simona, et al.
Publicado: (2023)

Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
por: Fattore, Luigi, et al.
Publicado: (2019)

Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma
por: Di Martile, Marta, et al.
Publicado: (2020)

Small molecules targeted to the microtubule–Hec1 interaction inhibit cancer cell growth through microtubule stabilization
por: Ferrara, M, et al.
Publicado: (2018)

Bcl-2 family inhibitors sensitize human cancer models to therapy
por: Valentini, Elisabetta, et al.
Publicado: (2023)

TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
por: Dinami, Roberto, et al.
Publicado: (2020)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
por: Allegretti, Matteo, et al.
Publicado: (2018)

Workshop on Colloid Physics : Festschrift Rudolph Klein on the occasion of his 60th birthday
por: Akcasu, A Z, et al.
Publicado: (1995)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions
por: Bruschini, Sara, et al.
Publicado: (2019)

Metabolite profiling of ascidian Styela plicata using LC–MS with multivariate statistical analysis and their antitumor activity
por: Palanisamy, Satheesh Kumar, et al.
Publicado: (2017)

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
por: Allegretti, Matteo, et al.
Publicado: (2023)

BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer
por: Conciatori, Fabiana, et al.
Publicado: (2020)

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vb10gul77n73vg7qv2k0rn03fg